ImmunologybioRxivPreprint
Viral soluble decoy receptor as a novel treatment for IFN-I triggered diseases
Francisco Javier Alvarez-de Miranda, Isabel Alonso-Sánchez, Pilar Delgado…·Antonio Alcamı́
This study explores the use of viral IFN-I binding protein as a therapeutic to neutralize IFN-I and treat autoinflammatory diseases in mouse models.
DOI 10.1101/2025.08.12.669887